Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes.
Acinetobacter baumannii is characterized by a rapid development of resistance to the commonly used antimicrobial agents. We investigated the risk factors, clinical features, and outcomes in ventilator-associated pneumonia (VAP) caused by extensive drug-resistant Acinetobacter baumannii (XDRAB). Clinical parameters and overall in-hospital mortality rates were compared between the VAP with and without XDRAB infection groups. This study showed that VAP caused by XDRAB was not associated with in-hospital mortality. However, it was related to high Simplified Acute Physiology Score II scores and increasing durations of hospital stays.
Department of Chest Diseases, Mersin University School of Medicine, Mersin, Turkey.
Eylem Sercan
ES
Özgür
Department of Infection Disease, Mersin University School of Medicine, Mersin, Turkey. Electronic address: sahinelif@gmail.com.
Elif Sahin
ES
Horasan
Department of Cardiovascular Surgery, Mersin University School of Medicine, Mersin, Turkey.
Kerem
K
Karaca
Department of Infection Disease, Mersin University School of Medicine, Mersin, Turkey.
Gülden
G
Ersöz
Department of Chest Diseases, Mersin University School of Medicine, Mersin, Turkey.
Sibel
S
Naycı Atış
Department of Infection Disease, Mersin University School of Medicine, Mersin, Turkey.
Ali
A
Kaya
D000151:Acinetobacter Infections / Q000453:epidemiology* / Q000382:microbiology / Q000401:mortality / Q000473:pathology*; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000302:isolation & purification; D000328:Adult; D000368:Aged; D015331:Cohort Studies; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D053717:Pneumonia, Ventilator-Associated / Q000453:epidemiology* / Q000382:microbiology / Q000401:mortality / Q000473:pathology*; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D016896:Treatment Outcome
Acinetobacter baumannii; Outcome; SAPS II; Simplified Acute Physiology Score II; Ventilator-associated pneumonia